Suchergebnisse - "Klempner, Samuel J"

PubPharm (8)

1

Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer

enthalten in: Cancer discovery | 2024

von An, M. | Mehta, A. | Min, B. | +16

2

Are You a TMBeliever? Mutations and Atezolizumab Response in Solid Tumors

enthalten in: Cancer discovery | 2022

von Maron, S. | Klempner, S.

CommentOn: Cancer Discov. 2022 Mar 1;12(3):654-669. - PMID 34876409

3

Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers

enthalten in: Molecular cancer therapeutics | 2021

von Klempner, S. | Bendell, J. | Villaflor, V. | +8

4

Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer

enthalten in: Cancer discovery | 2021

von Kwon, M. | An, M. | Klempner, S. | +14

CommentIn: Cancer Discov. 2021 Sep;11(9):2126-2128. - PMID 34479973

5

Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden

enthalten in: Clinical colorectal cancer | 2019

von Gong, J. | Robertson, M. | Kim, E. | +9

6

Ramucirumab plus pembrolizumab : can we make the maths work?

enthalten in: The Lancet. Oncology | 2019

von Klempner, S. | Wainberg, Z.

CommentOn: Lancet Oncol. 2019 Aug;20(8):1109-1123. - PMID 31301962

7

Initial Report of Second-Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas : A Multi-Institutional Retrospective Analysis

enthalten in: The oncologist | 2019

von Klempner, S. | Maron, S. | Chase, L. | +3

8

Safety of cupping during bevacizumab therapy

enthalten in: Journal of alternative and complementary medicine (New York, N.Y.) | 2013

von Klempner, S. | Costa, D. | Wu, P. | +1

1
[1]